Clinical Trials Browser

Has announcements × Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer × Erlotinib Hydrochloride × Clear all

NCT02296125 2026-04-21

FLAURA

Phase 3 Completed

674 enrolled 21 charts 1 FDA

Thoracic

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer